Cancer Therapy
Outlook for multiple myeloma improves due to new therapies
Published in Blood Weekly, January 4th, 2007
At the 2006 American Society of Hematology (ASH) Annual Meeting, these investigators are presenting results from five studies that tested new therapies in myeloma in order to improve effectiveness and reduce toxicity. The primary treatments being studied are the agents thalidomide (Thalomid), lenalidomide (Revlimid), and bortezomib (Velcade), that disrupt the microenvironment - the cellular habitat - of the tumor. Lenalidomide and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-01-04)
More Articles from Blood Weekly
- Blood Substitutes
New data from University of California, Department of Bioengineering illuminate research in blood substitutes - Influenza
Research from University of California provide new insights into influenza - Sepsis
Researchers from Sapporo Medical University, Department of Anesthesiology describe findings in sepsis - Sepsis Epidemiology
Scientists at National Institute of Allergy and Infectious Disease target sepsis epidemiology - Sepsis Epidemiology
Studies from Curtin University of Technology have provided new data on sepsis epidemiology - Sepsis Epidemiology
Westmead Hospital publishes research in sepsis epidemiology - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
